2026-2030年全球藥品包裝市場

全球藥品包裝市場預計在 2025 年至 2030 年間成長至 916.116 億美元，預測期內複合年成長率為 10.3%。

本報告對全球藥品包裝市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及對約 25 家公司的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括：複雜生物製藥和注射療法在全球範圍內的快速擴張、人口結構向老齡化轉變以及由此導致的慢性病增加、外包業務的擴張以及專業合約開發業務的蓬勃發展。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告還包含歷史數據和預測數據。

本研究指出，智慧連網包裝解決方案的加速普及將是未來幾年全球醫藥包裝市場成長的關鍵促進因素之一。此外，多模態人工智慧和機器視覺技術在包裝檢測線中的系統性整合，以及環保型、主動式和智慧型氣體吸收包裝架構的廣泛應用，預計也將產生巨大的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球藥品包裝市場
• 2020-2024年基於材料的細分市場分析
• 產品細分市場分析，2020-2024 年
• 按給藥途徑分類的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球藥品包裝市場
• 地緣政治衝突的影響：全球藥品包裝市場

第7章：五力分析

第8章 市場區隔：依材料

• 對比：按材料
• 硬質塑膠
• 軟質塑膠
• 玻璃
• 其他
• 市場機會：依材料分類

第9章 市場區隔：依產品

• 比較：按產品
• 塑膠瓶
• 蓋子和封口
• 吸塑包裝
• 預填充式注射器
• 其他
• 市場機會：依產品分類

第10章 市場區隔：依給藥途徑

• 比較：按給藥途徑
• 口服藥物
• 注射藥物
• 外用
• 鼻腔
• 其他
• 市場機會：依給藥途徑分類

第11章 客戶情況

第12章 區域情勢

• 區域分類
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 瑞士
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 印尼
• 中東和非洲
  • 沙烏地阿拉伯
  • 土耳其
  • 南非
  • UAE
  • 埃及
• 南美洲
  • 巴西
  • 阿根廷
  • 智利
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Amcor Plc
• AptarGroup Inc.
• Becton Dickinson and Co.
• Datwyler Holding Inc.
• Dow Chemical Co.
• Drug Plastics Group
• DS Smith Plc
• DuPont de Nemours Inc.
• Gerresheimer AG
• International Paper Co.
• Jabil Inc.
• Smurfit Westrock plc
• Sonoco Products Co.
• Stevanato Group SpA
• Vitro SAB De CV

第16章附錄

The global pharmaceutical packaging market is forecasted to grow by USD 91611.6 mn during 2025-2030, accelerating at a CAGR of 10.3% during the forecast period. The report on the global pharmaceutical packaging market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rapid global expansion of complex biologics and injectable therapeutics, demographic shift toward aging populations and accompanying rise in chronic conditions, increasing outsource architecture and proliferation of specialized contract development.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global pharmaceutical packaging market is segmented as below:

By Material

• Rigid plastic
• Flexible plastic
• Glass
• Others

By Product

• Plastic bottles
• Caps and closures
• Blister packs
• Pre-fillable syringes
• Others

By Route Of Administration

• Oral drugs
• Injectables
• Topical
• Nasal
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Switzerland
• APAC
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
• Middle East and Africa
  • Turkey
  • South Africa
  • UAE
  • Egypt
• South America
  • Brazil
  • Argentina
  • Chile
• Rest of World (ROW)

This study identifies the accelerated deployment of intelligent connected smart packaging solutions as one of the prime reasons driving the global pharmaceutical packaging market growth during the next few years. Also, systematic integration of multimodal ai and machine vision into packaging inspection lines and pervasive implementation of eco-friendly active and intelligent gas-scavenging packaging architectures will lead to sizable demand in the market.

The report on the global pharmaceutical packaging market covers the following areas:

• Global pharmaceutical packaging market sizing
• Global pharmaceutical packaging market forecast
• Global pharmaceutical packaging market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global pharmaceutical packaging market vendors that include ACG Group, Amcor Plc, AptarGroup Inc., Becton Dickinson and Co., Catalent Inc., Datwyler Holding Inc., Dow Chemical Co., Drug Plastics Group, DS Smith Plc, DuPont de Nemours Inc., Gerresheimer AG, International Paper Co., Jabil Inc., KP Holding GmbH and Co. KG, Perlen Packaging AG, Smurfit Westrock plc, Sonoco Products Co., Stevanato Group S.p.A, Vitro SAB De CV, West Pharma Services Inc.. Also, the global pharmaceutical packaging market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Material
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Pharmaceutical Packaging Market 2020 - 2024
  • Historic Market Size - Data Table on Global Pharmaceutical Packaging Market 2020 - 2024 ($ million)
• 5.2 Material segment analysis 2020 - 2024
  • Historic Market Size - Material Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 Route of Administration segment analysis 2020 - 2024
  • Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global pharmaceutical packaging market
• 6.2 Impact of geopolitical conflicts on global pharmaceutical packaging market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Material

• 8.1 Market segments
• 8.2 Comparison by Material
• 8.3 Rigid plastic - Market size and forecast 2025-2030
• 8.4 Flexible plastic - Market size and forecast 2025-2030
• 8.5 Glass - Market size and forecast 2025-2030
• 8.6 Others - Market size and forecast 2025-2030
• 8.7 Market opportunity by Material
  • Market opportunity by Material ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 Plastic bottles - Market size and forecast 2025-2030
• 9.4 Caps and closures - Market size and forecast 2025-2030
• 9.5 Blister packs - Market size and forecast 2025-2030
• 9.6 Pre-fillable syringes - Market size and forecast 2025-2030
• 9.7 Others - Market size and forecast 2025-2030
• 9.8 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by Route of Administration

• 10.1 Market segments
• 10.2 Comparison by Route of Administration
• 10.3 Oral drugs - Market size and forecast 2025-2030
• 10.4 Injectables - Market size and forecast 2025-2030
• 10.5 Topical - Market size and forecast 2025-2030
• 10.6 Nasal - Market size and forecast 2025-2030
• 10.7 Others - Market size and forecast 2025-2030
• 10.8 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 France - Market size and forecast 2025-2030
  • 12.4.3 UK - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 Switzerland - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Middle East and Africa - Market size and forecast 2025-2030
  • 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.2 Turkey - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 Egypt - Market size and forecast 2025-2030
• 12.7 South America - Market size and forecast 2025-2030
  • 12.7.1 Brazil - Market size and forecast 2025-2030
  • 12.7.2 Argentina - Market size and forecast 2025-2030
  • 12.7.3 Chile - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rapid global expansion of complex biologics and injectable therapeutics
  • Demographic shift toward aging populations and accompanying rise in chronic conditions
  • Increasing outsource architecture and proliferation of specialized contract development
• 13.2 Market challenges
  • Striking balance between rigid regulatory sterility standards
  • Managing raw material price volatility and high supply chain vulnerability
  • Combating advanced counterfeiting and guaranteeing secure end-to-end digital traceability
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Accelerated deployment of intelligent connected smart packaging solutions
  • Systematic integration of multimodal AI and machine vision into packaging inspection lines
  • Pervasive implementation of eco-friendly active and intelligent gas-scavenging packaging architectures

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Amcor Plc
  • Amcor Plc - Overview
  • Amcor Plc - Business segments
  • Amcor Plc - Key offerings
  • Amcor Plc - Segment focus
  • SWOT
• 15.5 AptarGroup Inc.
  • AptarGroup Inc. - Overview
  • AptarGroup Inc. - Business segments
  • AptarGroup Inc. - Key news
  • AptarGroup Inc. - Key offerings
  • AptarGroup Inc. - Segment focus
  • SWOT
• 15.6 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.7 Datwyler Holding Inc.
  • Datwyler Holding Inc. - Overview
  • Datwyler Holding Inc. - Business segments
  • Datwyler Holding Inc. - Key offerings
  • Datwyler Holding Inc. - Segment focus
  • SWOT
• 15.8 Dow Chemical Co.
  • Dow Chemical Co. - Overview
  • Dow Chemical Co. - Business segments
  • Dow Chemical Co. - Key offerings
  • Dow Chemical Co. - Segment focus
  • SWOT
• 15.9 Drug Plastics Group
  • Drug Plastics Group - Overview
  • Drug Plastics Group - Product / Service
  • Drug Plastics Group - Key offerings
  • SWOT
• 15.10 DS Smith Plc
  • DS Smith Plc - Overview
  • DS Smith Plc - Product / Service
  • DS Smith Plc - Key news
  • DS Smith Plc - Key offerings
  • SWOT
• 15.11 DuPont de Nemours Inc.
  • DuPont de Nemours Inc. - Overview
  • DuPont de Nemours Inc. - Business segments
  • DuPont de Nemours Inc. - Key news
  • DuPont de Nemours Inc. - Key offerings
  • DuPont de Nemours Inc. - Segment focus
  • SWOT
• 15.12 Gerresheimer AG
  • Gerresheimer AG - Overview
  • Gerresheimer AG - Business segments
  • Gerresheimer AG - Key offerings
  • Gerresheimer AG - Segment focus
  • SWOT
• 15.13 International Paper Co.
  • International Paper Co. - Overview
  • International Paper Co. - Business segments
  • International Paper Co. - Key news
  • International Paper Co. - Key offerings
  • International Paper Co. - Segment focus
  • SWOT
• 15.14 Jabil Inc.
  • Jabil Inc. - Overview
  • Jabil Inc. - Business segments
  • Jabil Inc. - Key offerings
  • Jabil Inc. - Segment focus
  • SWOT
• 15.15 Smurfit Westrock plc
  • Smurfit Westrock plc - Overview
  • Smurfit Westrock plc - Business segments
  • Smurfit Westrock plc - Key offerings
  • Smurfit Westrock plc - Segment focus
  • SWOT
• 15.16 Sonoco Products Co.
  • Sonoco Products Co. - Overview
  • Sonoco Products Co. - Business segments
  • Sonoco Products Co. - Key offerings
  • Sonoco Products Co. - Segment focus
  • SWOT
• 15.17 Stevanato Group S.p.A
  • Stevanato Group S.p.A - Overview
  • Stevanato Group S.p.A - Product / Service
  • Stevanato Group S.p.A - Key offerings
  • SWOT
• 15.18 Vitro SAB De CV
  • Vitro SAB De CV - Overview
  • Vitro SAB De CV - Business segments
  • Vitro SAB De CV - Key offerings
  • Vitro SAB De CV - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations